In This Section

Matthew C. Hocking, PhD
Matthew C Hocking Headshot

Dr. Hocking’s research aims to better understand the neurodevelopmental consequences of having survived childhood cancer or having neurofibromatosis type 1, to identify those who are most at risk for poor outcomes, and to intervene in some way in order to improve quality of life.



Subscribe to be notified of changes or updates to this page.


Dr. Hocking’s research focuses on the risk and resilience factors associated with the neurodevelopmental outcomes of children and young adults diagnosed with brain tumors, solid tumors and neurofibromatosis type 1 (NF1). The goal of this work is to enhance functional outcomes and overall quality of life for pediatric cancer survivors and their families.

Two ongoing studies are focused on assessing the social competency of pediatric brain tumor survivors. Dr. Hocking is evaluating the ability of these children to achieve personal goals through social interactions while maintaining positive interpersonal relationships with friends and family. One study represents an innovative collaboration with researchers from the Center for Autism Research that uses eyetracking technology and neuroimaging approaches to compare brain tumor survivors to youth with autism spectrum disorder (ASD) and typically developing youth to identify brain-related mechanisms for survivor social problems.

Other current studies include using neuroimaging methods to identify neurobiological factors associated with an ASD diagnosis in youth with NF1, a group with higher rates of ASD diagnoses than the general population, and determining whether germline genetic polymorphisms affect the risk for poor neurocognitive outcomes in pediatric brain tumor survivors.

Prior research integrated elements of family psychology, neuropsychology and developmental psychology to explain and address survivor neurodevelopmental late effects. In a series of studies, Dr. Hocking and his colleagues demonstrated that family functioning is an important variable that might mitigate the negative influence of neurocognitive late effects of pediatric brain tumors and represents a potential target in future interventions.

Among his career accomplishments to date are:

  • Receiving continuous National Institutes of Health funding since 2012 to study neurodevelopmental outcomes in youth with NF1 and in pediatric brain tumor survivors
  • Highlighting family functioning as important variable for pediatric brain tumor survivor health-related quality of life
  • Developing and co-chairing Psychosocial Grants Program for Alex’s Lemonade Stand Foundation


Education and Training

BA, University of North Carolina, Chapel Hill (Psychology), 2001

MA, University of Alabama (Clinical Child Psychology), 2005

PhD, University of Alabama (Clinical Child Psychology), 2009

Fellowship, Children's Hospital of Philadelphia (Pediatric Psychology), 2012

Titles and Academic Titles


Assistant Professor of Clinical Psychology

Professional Memberships

American Psychological Association, 2003-

Society of Pediatric Psychology, 2005-


Publication Highlights

Quast LF, Phillips PC, Li Y, Kazak AE, Barakat LP, and Hocking MC. A prospective study of family predictors of health-related quality of life in pediatric brain tumor survivors. Pediatr Blood Cancer. 2018 Jun; 65(6):e26976. PMID: 29350456
Hocking MC, Quast LF, Brodsky C, and Deatrick JA. Caregiver perspectives on the social competence of pediatric brain tumor survivors: A mixed-methods study. Support Care Cancer. 2017 Dec; 25(12):3749-3757. PMID: 28689249
Hocking MC, Hobbie WL, Deatrick JA, Hardie TL, and Barakat LP. Family functioning mediates the association between neurocognitive functioning and health-related quality of life in young adult survivors of childhood brain tumors. J Adolesc Young Adult Oncol. 2015 Mar; 4(1):18-25. PMID: 25852971
Hocking MC, McCurdy M, Turner E, Kazak AE, Noll, RB, and Barakat LP. Social competence in pediatric brain tumor survivors: application of a model from social neuroscience and developmental psychology. Pediatr Blood Cancer. 2015 Mar; 62(3):375-84. PMID: 25382825

Links of Interest